Brooks Automation, Inc.(USA)  

(Public, NASDAQ:BRKS)   Watch this stock  
Find more results for Brooks Automation Inc
12.37
+0.27 (2.23%)
Pre-market: 12.44 +0.07 (0.57%)
Dec 18, 5:24AM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.00 - 12.44
52 week 8.75 - 12.86
Open 12.12
Vol / Avg. 100.00/385,330.00
Mkt cap 810.48M
P/E 628.88
Div/yield 0.10/3.23
EPS 0.02
Shares 66.91M
Beta 1.70
Inst. own 91%
Feb 4, 2015
Q1 2015 Brooks Automation Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 15, 2015
Brooks Automation Inc at Needham Growth Conference - 10:40AM EST - Add to calendar
Dec 10, 2014
Brooks Automation Inc at Headgate Partners Midtown CAP Summit
Nov 12, 2014
Q4 2014 Brooks Automation Inc Earnings Call - Webcast
Nov 12, 2014
Q4 2014 Brooks Automation Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 0.29% 0.06%
Operating margin -0.52% -0.56%
EBITD margin - 5.65%
Return on average assets 0.18% 0.04%
Return on average equity 0.15% 0.21%
Employees 1,455 -
CDP Score - -

Address

15 Elizabeth Dr
CHELMSFORD, MA 01824-4111
United States - Map
+1-978-2622400 (Phone)
+1-978-2622500 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Brooks Automation, Inc. (Brooks) is a global provider of automation, vacuum and instrumentation solutions for multiple markets, including semiconductor manufacturing, technology device manufacturing and life sciences. The Company operates in four segments: Brooks Product Solutions, Brooks Global Services and Brooks Life Science Systems. On December 30, 2011, the Company acquired the Celigo automated Cell Cytometer product line (Celigo) from Cyntellect, Inc. On January 6, 2012, the Company acquired intangible assets from Intevac, Inc. On October 29, 2012, it acquired Crossing Automation Inc. (Crossing), a United States based provider of automation solutions for the global semiconductor front-end markets.

Officers and directors

Joseph R. Martin Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark D. Morelli President, Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Stephen S. Schwartz Ph.D. Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Lindon G. Robertson Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Maurice H. Tenney III President - Life Science Systems
Age: 50
Bio & Compensation  - Reuters
Kush K. Mirchandani Senior Vice President - Global Sales and Service
Age: 48
Bio & Compensation  - Reuters
William T. Montone Senior Vice President - Human Resources
Age: 61
Bio & Compensation  - Reuters
David F. Pietrantoni Principal Accounting Officer, Vice President - Finance, Corporate Controller
Age: 41
Bio & Compensation  - Reuters
Jason W. Joseph Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
A. Clinton Allen Independent Director
Bio & Compensation  - Reuters